Hisun Pharmaceutical Exports Fluvastatin To Europe
This article was originally published in PharmAsia News
Executive Summary
Hisun Pharmaceutical shipped 900,000 fluvastatin capsules to Europe in November. It is the first China enterprise to cooperate with an overseas partner to enter the EU under its branded pharmaceutical formulation. Hisun collaborates with a German drug manufacturer to apply for European pharmaceutical certifications for its fluvastatin formulation and received approval in August. Even though the fluvastatin export will not contribute substantially to the firm's profit in the short term, it paves the way for Hisun's strategic shift from the production of active pharmaceutical ingredients to higher value-added co-development of APIs and formulations. (Click here for more - Chinese language)